Which one is better, Sotoraxibu or Adagalasib?

Sotorasib and Adagrasib are two different anti-cancer drugs used to treat specific types of tumors. They are targeted therapeutic drugs that can target specific gene mutations or abnormal signaling pathways in tumor cells.

Adagrasiib is another targeted therapy for patients with non-small cell lung cancer who carry the KRAS G12C mutation. While adagrasib has shown promise in early clinical trials, as received approval from regulatory agencies such as the U.S. Food and Drug Administration (FDA) for the treatment of lung cancer, preliminary data from ongoing clinical trials suggest that adagrasib may have similar efficacy to sotorasib, potentially providing clinical benefit to patients with this specific genetic alteration.

Sotoracib is a drug specifically designed to treat non-small cell lung cancer with a special KRAS G12C gene mutation. This mutation is present in a subset of patients with non-small cell lung cancer and has historically been considered a challenging target for therapy. Itsefficacy in lung cancer was confirmed in trials with significant efficacy in tumor shrinkage and disease control in patients with KRAS G12C mutations who had previously received chemotherapy and/or immunotherapy.

In early clinical trial results, adagrasiib's ORR was comparable to that of sotoracib, and a large number of patients experienced tumor shrinkage. The DCR for adagrasib was also high, indicating that most patients achieved stable disease or better. The PFS data, while still maturing, suggest that adagrasib has the potential to be an effective treatment option for patients with KRAS G12C mutant NSCLC.

Sinceadagrasibthe original drug has not yet been launched in China, patients can only purchase adagrasib through overseas channels, and the U.S. original version of 200mg*180 tablets is priced at hundreds of thousands of yuan per box (the price may fluctuate due to exchange rates), which is very expensive. Currently, there are no generic drugs of adagrasib produced overseas. For more drug information and specific prices, please consult Yaode’s medical consultant.